PETVOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
PetVivo Holdings, Inc.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.75+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $27.79M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.6000 (−44.44%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
PetVivo Holdings, Inc. saw revenue fall 9.5% to $1.18M over the twelve months to Jun 30, 2026. Free cash flow was -$6.12M.
Revenue
$1.18M
-9.5% vs. a year earlier
Operating income
-$8.83M
TTM Q1 2027
Free cash flow
-$6.12M
FY2026
EPS, diluted
-$0.31
TTM Q1 2027
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $27.79M
- P/E ratio
- –
- Price to sales
- 23.52
- Price to book
- 20.49
- Dividend yield
- –
- Free cash flow yield
- -22.00%
Fundamentals
- Revenue
- $1.18M
- Net income
- -$9.78M
- EPS, diluted
- -$0.31
- Free cash flow
- -$6.12M
- Book value per share
- $0.04
- Diluted shares
- 37M
Fifteen years at a glance
Fiscal years 2012 to 2026 and trailing twelve months, USD
Revenue
$1.18M-9.5% YoY
Gross profit
$791.34K-26.1% YoY
Operating income
-$8.83M
Net income
-$9.78M
EPS, diluted
-$0.31
Free cash flow
–
Reported periodTrailing twelve months